BMS-986484
/ BMS
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 18, 2026
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=213 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Active, not recruiting
Enrollment closed • First-in-human • Monotherapy • Colorectal Cancer • Esophageal Cancer • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Head and Neck Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Pancreatic Ductal Adenocarcinoma • Solid Tumor • Squamous Cell Carcinoma of Head and Neck
August 18, 2025
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=213 | Recruiting | Sponsor: Bristol-Myers Squibb | N=134 ➔ 213
Enrollment change • Monotherapy • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1